Travatan

Travatan Dosage/Direction for Use

travoprost

Manufacturer:

Novartis

Distributor:

Zuellig
/
Firma Chun Cheong
Full Prescribing Info
Dosage/Direction for Use
Posology: Use in adults, including elderly population: The dose is one drop of TRAVATAN eye drops in the conjunctival sac of the affected eye(s) once daily.
Optimal effect is obtained if the dose is administered in the evening.
Nasolacrimal occlusion or gently closing the eyelid after administration is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions.
If more than one topical ophthalmic medicinal product is being used, the medicinal products must be administered at least 5 minutes apart (see Interactions).
If a dose is missed, treatment should be continued with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily.
When substituting another ophthalmic antiglaucoma medicinal product with TRAVATAN eye drops, the other medicinal product should be discontinued and TRAVATAN eye drops should be started the following day.
Hepatic and renal impairment: TRAVATAN eye drops have been studied in patients with mild to severe hepatic impairment and in patients with mild to severe renal impairment (creatinine clearance as low as 14 ml/min). No dosage adjustment is necessary in these patients (see Pharmacology: Pharmacokinetics under Actions).
Paediatric population: TRAVATAN eye drops can be used in paediatric patients from 2 months to < 18 years at the same posology as in adults. However, data in the age group 2 months to < 3 years (9 patients) is limited (see Pharmacology: Pharmacodynamics under Actions).
The safety and efficacy of TRAVATAN eye drops in children below the age of 2 months have not been established. No data are available.
Method of Administration: For ocular use.
For patients who wear contact lenses, please refer to Precautions.
The patient should remove the protective overwrap immediately prior to initial use. To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in